Skip to main navigation Skip to search Skip to main content

Epithelioid Hemangioendothelioma and Epithelioid Hemangioma: Pazopanib as a Potential Salvage Therapy

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Epithelioid hemangioma (EH) and epithelioid hemangioendothelioma (EHE) are both rare vascular tumors. EH tumors are often benign while EHE tumors have moderate malignant potential. Here, we present three unique cases at Soroka Medical Center, two featuring EH of the bone and one presenting EHE of the mediastinum. Each case demonstrates distinct treatment challenges due to the rarity of both diseases and lack of established guidelines. We propose three treatment approaches including pazopanib for salvage therapy of EH of the bone and minimally invasive surgical resection which in these cases lead to complete symptom relief and tumor stabilization upheld over time with close follow-up.

Original languageEnglish
Pages (from-to)309-317
Number of pages9
JournalCase Reports in Oncology
Volume14
Issue number1
DOIs
StatePublished - 1 Jan 2021

Keywords

  • Epithelioid hemangioendothelioma
  • Pazopanib
  • Rib epithelioid hemangioma

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Epithelioid Hemangioendothelioma and Epithelioid Hemangioma: Pazopanib as a Potential Salvage Therapy'. Together they form a unique fingerprint.

Cite this